Medical Writing Market Drivers and Opportunities: Increasing Adoption of Regulatory and Scientific Writing Services According to The Insight Partners, the medical writing market size is projected to reach US$ 9,114.91 million by 2031 from US$ 3,931.50 million in 2023. The market is expected to register a CAGR of 11.1% during 2023–2031. The implementation of artificial intelligence (AI) in medical writing is likely to introduce new trends in the market during the coming years. AI-enabled tools can support document generation, content organization, data interpretation, and quality checks while allowing professional medical writers to retain oversight of scientific accuracy and regulatory compliance. The growing importance of medical writing in obtaining regulatory approvals, increasing preference for CROs, and rising demand for regulatory and clinical trial documentation are key factors supporting market growth. Read More - https://www.theinsightpartners.com/reports/medical-writing-market

Home Medical Devices Market Drivers and Opportunities: Increasing Adoption of Patient-Centric Healthcare Solutions The Home Medical Devices Market size is expected to reach US$86.70 billion by 2034 from US$46.82 billion in 2025. The market is anticipated to register a Compound Annual Growth Rate (CAGR) of 7.12% during 2026–2034. Read More - https://www.theinsightpartners.com/reports/home-medical-devices-market

Global Neuroprotection Market Overview: Industry Insights and Future Outlook to 2034 Read More - https://www.theinsightpartners.com/reports/neuroprotection-market According to The Insight Partners, the Neuroprotection Market was valued at US$ 23.36 billion in 2024 and is expected to reach US$ 38.75 billion by 2031, registering a CAGR of 7.5% during 2025–2031. The report also estimates the total addressable market at approximately US$ 220.67 billion during 2025–2031. This expansion reflects the increasing burden of neurodegenerative diseases and technological progress in neuroscience. An aging global population is a major growth driver because the risk of age-related neurological conditions increases with advancing age. At the same time, advances in research and technology are improving understanding of neurodegeneration and supporting the development of targeted interventions.